[HTML][HTML] Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development

L Wang, Y Yan, L Wu, J Peng - Pharmacological Research, 2023 - Elsevier
With changing lifestyles, non-alcoholic fatty liver disease (NAFLD) has become the most
prevalent liver disease worldwide. A substantial increase in the incidence, mortality, and …

Therapeutic potential of natural compounds in subarachnoid haemorrhage

J Tan, H Zhu, Y Zeng, J Li, Y Zhao, M Li - Neuroscience, 2024 - Elsevier
Subarachnoid hemorrhage (SAH) is a common and fatal cerebrovascular disease with high
morbidity, mortality and very poor prognosis worldwide. SAH can induce a complex series of …

17β-Estradiol protects female rats from bilateral oophorectomy-induced nonalcoholic fatty liver disease induced by improving linoleic acid metabolism alteration and …

Y Tian, Y Xie, X Hong, Z Guo, Q Yu - Heliyon, 2024 - cell.com
After surgical or natural menopause, women face a high risk of nonalcoholic fatty liver
disease (NAFLD), which can be diminished by hormone replacement therapy (HRT). The …

Improving determination of pigment contents in microalgae suspension with absorption spectroscopy: Light scattering effect and Bouguer–Lambert–Beer law

YC Yeh, T Ebbing, K Frick, U Schmid-Staiger… - Marine Drugs, 2023 - mdpi.com
The Bouguer–Lambert–Beer (BLB) law serves as the fundamental basis for the
spectrophotometric determination of pigment content in microalgae. Although it has been …

Fucoxanthin Mitigates High-Fat-Induced Lipid Deposition and Insulin Resistance in Skeletal Muscle through Inhibiting PKM1 Activity

C Wu, C Zhang, F Li, Y Yan, Y Wu, B Li… - Journal of Agricultural …, 2024 - ACS Publications
Glucose and lipid metabolism dysregulation in skeletal muscle contributes to the
development of metabolic disorders. The efficacy of fucoxanthin in alleviating lipid metabolic …

[PDF][PDF] Effectiveness of Resmetirom in Reducing Cholesterol Levels in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis

E Bejitual, MF Awais, D Modi, U Gul, K Obeidat… - Cureus, 2024 - cureus.com
Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease
(NAFLD) associated with metabolic syndrome and increased cardiovascular risk …

Strategies for Total Synthesis of Fucoxanthin from a Commercial Perspective

SD Gupta, CH Pan - thieme-connect.com
Fucoxanthin, the light-harvesting pigment of various algae has shown promising biological
activity in pre-clinical and clinical models. It has also received marketing approval as a …

Correlation of non-alcoholic fatty liver disease and gut microflora: clinical reports and treatment options

PA Jadhav, AB Thomas, RK Nanda, SS Chitlange - Egyptian Liver Journal, 2024 - Springer
A prevalent liver condition called non-alcoholic fatty liver disease (NAFLD) may progress
into non-alcoholic steatohepatitis (NASH) and cause life-threatening complications like …